Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine > Articles by: Janet Fricker

Posts by author

Janet Fricker

230 posts
Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.
Bacterial decolonisation offers new strategy to prevent acute radiation dermatitis
View Post
  • News

Bacterial decolonisation offers new strategy to prevent acute radiation dermatitis

  • Janet Fricker
  • 1 June 2023

Many cases of acute radiation dermatitis involve the common skin bacterium Staphylococcus aureus. Two linked papers in the same issue of JAMA Oncology, published online 4 May, suggest bacterial decolonisation of Staphylococcus aureus (S aureus) offers an effective approach for…

View Post
Slow decrease in breast density heightens breast cancer risk
View Post
  • News

Slow decrease in breast density heightens breast cancer risk

  • Janet Fricker
  • 31 May 2023

Women with a slower decrease in breast density over time are at higher risk of developing breast cancer. The prospective cohort study, published in JAMA Oncology, online April 27, suggests that dynamic changes in breast density over time can be…

View Post
Prehabilitation programmes benefit breast cancer patients and save healthcare resources
View Post
  • News

Prehabilitation programmes benefit breast cancer patients and save healthcare resources

  • Janet Fricker
  • 19 May 2023

Referring patients with early-stage breast cancer to exercise programmes prior to surgery not only improves health-related quality of life measures but also lowers overall healthcare costs. The study, abstract 1385675, was presented at the American Society of Breast Surgeons Annual…

View Post
Using ultrasound to open blood–brain barrier could be glioblastoma game changer
View Post
  • News

Using ultrasound to open blood–brain barrier could be glioblastoma game changer

  • Janet Fricker
  • 18 May 2023

A novel ultrasound device temporarily opens the blood–brain barrier to allow delivery of chemotherapy. The dose-escalation phase 1 study, published in Lancet Oncology, May 2, provides evidence that use of the new French technology leads to a fourfold increase in…

View Post
Genetic targets identified for cancer-associated cachexia
View Post
  • News

Genetic targets identified for cancer-associated cachexia

  • Janet Fricker
  • 5 May 2023

Distinct patterns of genes have been shown to be active in the tumours of non-small-cell lung cancer patients who go on to develop cachexia, including high activity of the protein GDF15. The study, published in Nature Medicine, April 2023 issue,…

View Post
Antimicrobial exposure linked to poorer survival in triple negative breast cancer
View Post
  • News

Antimicrobial exposure linked to poorer survival in triple negative breast cancer

  • Janet Fricker
  • 4 May 2023

Each additional total or unique monthly antimicrobial prescription is associated with inferior overall and breast-cancer-specific survival in women with triple negative breast cancer (TNBC). The study published in Nature Communications, 12 April 2023, found that the association was directly related…

View Post
Trial platform informs precision treatment of childhood cancers
View Post
  • News

Trial platform informs precision treatment of childhood cancers

  • Janet Fricker
  • 21 April 2023

A stratified medicine basket study has shown the benefit of combining two targeted therapies to treat paediatric cancers with specific molecular profiles. The study, presentation number CT019, presented at the AACR (American Association for Cancer Research) Annual Meeting 2023, held…

View Post
Personalised RNA vaccine combined with immune checkpoint inhibitor shows efficacy in melanoma
View Post
  • News

Personalised RNA vaccine combined with immune checkpoint inhibitor shows efficacy in melanoma

  • Janet Fricker
  • 18 April 2023

In advanced melanoma, adding a personalised mRNA-based vaccine to the immune checkpoint inhibitor pembrolizumab improved recurrence-free survival compared with pembrolizumab alone. The KEYNOTE-942 study (presentation number CT001), presented at the AACR (American Association for Cancer Research) Annual Meeting 2023, held…

View Post
Intermittent dosing of exemestane is non-inferior to daily dosing
View Post
  • News

Intermittent dosing of exemestane is non-inferior to daily dosing

  • Janet Fricker
  • 5 April 2023

Giving the aromatase inhibitor (AI) exemestane 25 mg three times weekly was non-inferior to the standard dosing of 25mg daily among study participants who complied with the schedule. The international, multicentric study, which was supported by the US National Cancer…

View Post
Body weight influences breast cancer risk in women with BRCA1 and 2 mutations
View Post
  • News

Body weight influences breast cancer risk in women with BRCA1 and 2 mutations

  • Janet Fricker
  • 5 April 2023

Obesity may be a factor contributing to DNA damage in the breast tissue of women with BRCA1 or BRCA2 mutations. The study, published in Science Translational Medicine, February 22, suggests maintaining a healthy body weight or pharmacologically targeting oestrogen or…

View Post

Posts pagination

Previous 1 … 8 9 10 11 12 … 23 Next
search
CancerWorld #106 Download CancerWorld #105 Download CancerWorld #105 Download CancerWorld #104 Download CancerWorld #103 Download CancerWorld #102 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • CancerWorld #107 (September 2025)
    • 5 September 2025
  • ESO College Voices Contest 2025: Social media – friend or foe for cancer patients? – Winners Announced
    • 31 August 2025
  • Six Months of CancerWorld Under p53: A Report of Renewal, Responsibility, and Reach
    • 19 August 2025
  • CancerWorld #106 (August 2025)
    • 15 August 2025
  • Cancer Neuroscience: How Neurons Fuel Tumor Growth, and What it Means for Therapy
    • 12 August 2025
Article
  • Princess Dina: The Voice for The Voiceless
    • 4 September 2025
  • Patrick Soon-Shiong: He Who Speaks for the People
    • 4 September 2025
  • I Am Alive: Letter to Oncologists
    • 1 September 2025
Social

Would you follow us ?

Contents
  • Princess Dina: The Voice for The Voiceless
    • 4 September 2025
  • Patrick Soon-Shiong: He Who Speaks for the People
    • 4 September 2025
  • I Am Alive: Letter to Oncologists
    • 1 September 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.